Mirae Asset Global ETFs Holdings
AVBP icon

Mirae Asset Global ETFs Holdings’s ArriVent BioPharma AVBP Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$704K Buy
20,294
+2,568
+14% +$75.8K ﹤0.01% 1816
2026
Q1 		$404K Buy
17,726
+2,348
+15% +$53K ﹤0.01% 1990
2025
Q4 		$310K Buy
15,378
+2,132
+16% +$44.4K ﹤0.01% 2138
2025
Q3 		$244K Sell
13,246
-157
-1% -$3.08K ﹤0.01% 2226
2025
Q2 		$293K Sell
13,403
-4,143
-24% -$86K ﹤0.01% 2080
2025
Q1 		$325K Buy
17,546
+432
+3% +$10.6K ﹤0.01% 2081
2024
Q4 		$456K Buy
17,114
+1,327
+8% +$38.1K ﹤0.01% 1966
2024
Q3 		$371K Buy
15,787
+10,906
+223% +$248K ﹤0.01% 2065
2024
Q2 		$90.5K Buy
+4,881
New +$87K ﹤0.01% 2605

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's AVBP Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its ArriVent BioPharma (AVBP) stake by 14% in Q2 2026, buying an estimated $75.8K and bringing the position to 20,294 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #1816.

Mirae Asset Global ETFs Holdings first reported a position in AVBP in Q2 2024 and has held it in 9 quarters since. 157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 20,294 shares of ArriVent BioPharma worth $704K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 2,568 ArriVent BioPharma shares in Q2 2026, an estimated $75.8K.
  • ArriVent BioPharma made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1816 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in ArriVent BioPharma in Q2 2024 and has held it in 9 quarters since.
  • 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.